Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
MARITIME-2
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2)
1 other identifier
interventional
1,105
13 countries
187
Brief Summary
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Mar 2025
187 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2025
CompletedFirst Posted
Study publicly available on registry
March 5, 2025
CompletedStudy Start
First participant enrolled
March 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 16, 2027
December 31, 2025
December 1, 2025
1.8 years
February 28, 2025
December 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent Change from Baseline in Body Weight at Week 72
Baseline and Week 72
Secondary Outcomes (28)
Change from Baseline in Waist Circumference at Week 72
Baseline and Week 72
Participant achieving ≥ 5% reduction in body weight from baseline at week 72
Baseline and Week 72
Participant achieving ≥ 10% reduction in body weight from baseline at week 72
Baseline and Week 72
Participant achieving ≥ 15% reduction in body weight from baseline at week 72
Baseline and Week 72
Change from Baseline in Systolic Blood Pressure (SBP) at Week 72
Baseline and Week 72
- +23 more secondary outcomes
Study Arms (4)
Maridebart Cafraglutide High Dose
EXPERIMENTALParticipants will receive maridebart cafraglutide high dose subcutaneously (SC) for 72 weeks.
Maridebart Cafraglutide Medium Dose
EXPERIMENTALParticipants will receive maridebart cafraglutide medium dose SC for 72 weeks.
Maridebart Cafraglutide Low Dose
EXPERIMENTALParticipants will receive maridebart cafraglutide low dose SC for 72 weeks.
Placebo
PLACEBO COMPARATORParticipants will receive placebo SC for 72 weeks.
Interventions
Maridebart cafraglutide will be adminstered SC.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Body mass index ≥ 27 kg/m\^2.
- History of at least 1 self-reported unsuccessful attempt at weight loss by diet and exercise.
- Diagnosis of T2DM.
You may not qualify if:
- Type 1 diabetes mellitus.
- Self-reported change in body weight \> 5 kg within 90 days before screening.
- Proliferative diabetic retinopathy OR diabetic macular edema OR non-proliferative diabetic retinopathy that requires acute treatment.
- Obesity induced by other endocrinologic disorders.
- Family (first-degree relative\[s\]) or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2.
- History of chronic pancreatitis or history of acute pancreatitis within 180 days before screening.
- History of unstable major depressive disorder (MDD) or other severe psychiatric disorder within 2 years before screening.
- Lifetime history of suicide attempt.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amgenlead
Study Sites (187)
Alliance for Multispecialty Research Mobile
Mobile, Alabama, 36608, United States
Gilbert Center for Family Medicine
Gilbert, Arizona, 85296, United States
Desert Clinical Research
Mesa, Arizona, 85213, United States
Avacare Foothills Research Center
Phoenix, Arizona, 85044, United States
San Fernando Valley Health Institute
Canoga Park, California, 91304, United States
Core Healthcare Group
Cerritos, California, 90703, United States
Velocity Clinical Research Chula Vista
Chula Vista, California, 91911, United States
Headlands Research California
Escondido, California, 92025, United States
Paradigm Clinical Research
Modesto, California, 95355, United States
Flourish Research
Northridge, California, 91325, United States
University of California Irvine
Orange, California, 92868, United States
Empire Clinical Research
Pomona, California, 91767, United States
Infinity Clinical Trials
San Diego, California, 92108, United States
Greenwich Clinical Trials
Riverside, Connecticut, 06878, United States
Indago Research and Health Center
Hialeah, Florida, 33012, United States
Optimus U Corporation
Miami, Florida, 33135, United States
New Horizon Research Center
Miami, Florida, 33165, United States
San Marcus Research Clinic Inc
Miami Lakes, Florida, 33014, United States
Florida Institute for Clinical Research
Orlando, Florida, 32825, United States
Encore Medical Research of Weston LLC
Weston, Florida, 33331, United States
Conquest Research - Winter Park
Winter Park, Florida, 32789, United States
Alliance For Multispecialty Research - Oak Brook
Oak Brook, Illinois, 60523, United States
Alliance for Multispecialty Research, LLC - Park Ridge
Park Ridge, Illinois, 66068, United States
Endeavor Health Medical Group - Endocrinology and Diabetes- Skokie
Skokie, Illinois, 60077, United States
Indiana Medical Research Institute
Merrillville, Indiana, 46410, United States
Iowa Diabetes Research
West Des Moines, Iowa, 50266, United States
Alliance for Multispecialty Research Newton
Newton, Kansas, 67114, United States
Alliance for Multispecialty Research LLC
Wichita, Kansas, 67207, United States
Advanced Internal Medicine
Paducah, Kentucky, 42001, United States
Ima Clinical Research- Monroe
Monroe, Louisiana, 71201, United States
Annapolis Internal Medicine, LLC
Annapolis, Maryland, 21401, United States
Brigham and Womens Hospital
Boston, Massachusetts, 02115, United States
International Diabetes Center - HealthPartners Institute
Minneapolis, Minnesota, 55416, United States
Alliance for Multispecialty Research - Kansas City
Kansas City, Missouri, 64114, United States
Palm Research Center Inc
Las Vegas, Nevada, 89128, United States
Vector Clinical Trials
Sparks, Nevada, 89436, United States
Premier Research
Trenton, New Jersey, 08611, United States
Albany Medical College
Albany, New York, 12203, United States
Asheville Clinical Research
Asheville, North Carolina, 28803, United States
Physicians East
Greenville, North Carolina, 27834, United States
Carteret Medical Group
Morehead City, North Carolina, 28557, United States
West Clinical Research
Morehead City, North Carolina, 28557, United States
Velocity Clinical Research - Cincinnati
Blue Ash, Ohio, 45242, United States
Velocity Clinical Research - Springdale
Cincinnati, Ohio, 45246, United States
Velocity Clinical Research - Providence
East Greenwich, Rhode Island, 02818, United States
Medical Care LLC
Elizabethton, Tennessee, 37643, United States
Elligo Clinical Research Center
Austin, Texas, 78701, United States
Osvaldo A Brusco MD PA
Corpus Christi, Texas, 78414, United States
Cedar Health Research, LLC
Dallas, Texas, 75251, United States
Soma Clinical Trials, LLC
Denison, Texas, 75020, United States
Cedar Health Research, LLC
Euless, Texas, 76040, United States
Juno Research LLC
Houston, Texas, 77040, United States
Juno Research LLC
Houston, Texas, 77054, United States
Tekton Research
McKinney, Texas, 75069, United States
Northeast Clinical Research of San Antonio LLC
San Antonio, Texas, 78233, United States
Alliance for Multispecialty Research - Layton
Layton, Utah, 84041, United States
Manassas Clinical Research Center Inc
Manassas, Virginia, 20110, United States
VA Puget Sound Healthcare System
Seattle, Washington, 98108, United States
Ima Clinical Research - West Virginia
Morgantown, West Virginia, 26505, United States
Centro Medico Viamonte
CABA, Buenos Aires, 1120, Argentina
Cedic Centro de Investigacion Clinica
CABA, Buenos Aires, C1060ABN, Argentina
Cemedic Centro de Especialidades Medicas
CABA, Buenos Aires, C1407GTN, Argentina
Maffei Centro Medico
CABA, Buenos Aires, C1425AGC, Argentina
Consultorios Medicos Dr Besada
CABA, Buenos Aires, C1426ABP, Argentina
Cinme - Centro de Investigaciones Metabolicas
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1056ABI, Argentina
Ciprec Centro de Investigacion y Prevencion Cardiovascular
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1061AAT, Argentina
Ambulatory for specialized outpatient medical aid in endocrinology-Dr Albena Dinkova EOOD
Pleven, 5801, Bulgaria
Diagnostic - Consultative Center XX - Sofia EOOD
Sofia, 1404, Bulgaria
Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda EAD
Sofia, 1407, Bulgaria
University Multiprofile Hospital for Active Treatment Sofiamed OOD
Sofia, 1750, Bulgaria
Prevencia-2000-Medical center for outpatient medical aid OOD
Stara Zagora, 6000, Bulgaria
Medical Center Berbatov EOOD
Yambol, 8600, Bulgaria
tlc Diabetes and Endocrinology
Surrey, British Columbia, V3T 2V6, Canada
Chronic Disease Innovation Centre
Winnipeg, Manitoba, R2V 3M3, Canada
Nova Scotia Health Authority, Queen Elizabeth ii Health Sciences Centre
Halifax, Nova Scotia, B3H 2Y9, Canada
Centricity Research Brampton
Brampton, Ontario, L6S 0C6, Canada
Aggarwal and Associates Ltd
Brampton, Ontario, L6T 0G1, Canada
Centricity Research Vaughan
Concord, Ontario, L4K 4M2, Canada
Winterberry Family Medicine
Hamilton, Ontario, L8J 0B6, Canada
Premier Clinical Trial Network
Hamilton, Ontario, L8L 5G4, Canada
Milestone Research
London, Ontario, N5W 6A2, Canada
Centricity Research Ottawa LMC
Nepean, Ontario, K2J 0V2, Canada
Your Research Network Inc.
Niagara Falls, Ontario, L2H 1H5, Canada
North York Diagnostic and Cardiac Centre
North York, Ontario, M6B 3H7, Canada
Bluewater Clinical Research Group Incorporated
Sarnia, Ontario, N7T 4X3, Canada
Albion Finch Medical Centre
Toronto, Ontario, M9V 4B4, Canada
Centricity Research Quebec City
Lévis, Quebec, G6W 0M5, Canada
Institut de recherches cliniques de Montreal
Montreal, Quebec, H2W 1R7, Canada
Centre Medical Acadie
Montreal, Quebec, H4N 2W2, Canada
Centricity Research Pointe-Claire
Pointe-Claire, Quebec, H9R 4S3, Canada
Diex Recherche Trois Rivieres
Trois-Rivières, Quebec, G9A 4P3, Canada
Fakultni nemocnice Brno
Brno, 625 00, Czechia
CCR Ostrava sro
Ostrava, 702 00, Czechia
Diahelp sro
Pardubice, 530 02, Czechia
Pratia Pardubice as
Pardubice, 530 02, Czechia
Fakultni nemocnice Kralovske Vinohrady
Prague, 100 34, Czechia
Vseobecna fakultni nemocnice v Praze
Prague, 128 08, Czechia
Institut klinicke a experimentalni mediciny
Prague, 140 21, Czechia
Milan Kvapil sro
Prague, 149 00, Czechia
Restrial sro
Prague, 181 00, Czechia
Endokrinologie Cerny Most sro
Prague, 198 00, Czechia
Milan Kvapil sro
Pribram VIII, 261 01, Czechia
Universitatsklinikum Aachen
Aachen, 52074, Germany
Universitaets-Herzzentrum Freiburg - Bad Krozingen
Bad Krozingen, 79189, Germany
Diabetespraxis Bad Mergentheim
Bad Mergentheim, 97980, Germany
Universitaetsklinikum der Ruhr-Universitaet Bochum
Bad Oeynhausen, 32545, Germany
Charite - Universitaetsmedizin Berlin, Campus Mitte
Berlin, 10117, Germany
Velocity Clinical Research GmbH
Berlin, 10787, Germany
Diabetespraxis Dr. Hermann Braun
Berlin, 13187, Germany
Mvz am Bahnhof Spandau
Berlin, 13597, Germany
Zentrum fuer Klinische Studien Suedbrandenburg GmbH
Elsterwerda, 04910, Germany
InnoDiab Forschung
Essen, 45136, Germany
Schwerpunktpraxis fuer Diabetes, Gefaess- & Ernaehrungsmedizin
Falkensee, 14612, Germany
Diabeteszentrum Hamburg West
Hamburg, 22607, Germany
Endokrinologikum Hamburg
Hamburg, 22767, Germany
Diabetologische Schwerpunktpraxis Hohenmoelsen
Hohenmölsen, 06679, Germany
Universitaetsklinikum Leipzig
Leipzig, 04103, Germany
AmBeNet GmbH
Leipzig, 04107, Germany
Kardiologische Praxis Doktor Jens Taggeselle
Markkleeberg, 04416, Germany
Centrum für Diagnostik und Gesundheit
München, 80809, Germany
Zentrum fuer Diabtes und Gefaesskrankheiten im Franziskus Carré Muenster
Münster, 48145, Germany
Red-Institut GmbH
Oldenburg, 23758, Germany
Lausmed Kft
Baja, 6500, Hungary
DRC Gyogyszervizsgalo Kozpont Kft
Balatonfüred, 8230, Hungary
Clinexpert Kft
Budapest, 1033, Hungary
Obudai Egeszsegugyi Centrum Kft
Budapest, 1036, Hungary
ClinDiab Kft
Budapest, 1089, Hungary
MED-TIMA Kft
Budapest, 1132, Hungary
Borvo Clinic Kft
Debrecen, 4025, Hungary
Debreceni Egyetem Klinikai Kozpont
Debrecen, 4032, Hungary
Komaromi Selye Janos Korhaz
Komárom, 2900, Hungary
Borbanya Praxis Egeszsegugyi Kft
Nyíregyháza, 4405, Hungary
Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz
Szombathely, 9700, Hungary
IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico di Sant Orsola
Bologna, 40138, Italy
Universita degli Studi Gabriele D Annunzio di Chieti e Pescara
Chieti, 66100, Italy
Azienda Ospedaliero Universitaria Careggi
Florence, 50134, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
IRCCS Centro Cardiologico Monzino
Milan, 20138, Italy
Azienda Socio Sanitaria Territoriale Fatebenefratelli Sacco
Milan, 20157, Italy
Ospedale Civico, Di Cristina e Benfratelli
Palermo, 90127, Italy
Mikannohana Clinic, Diabetes, Endocrinology and Metabolism
Matsuyama, Ehime, 790-0034, Japan
Morizono Medical Clinic
Kitakyusyu-shi, Fukuoka, 807-0072, Japan
Mazda Hospital of Mazda Motor Corporation
Aki-gun, Hiroshima, 735-8585, Japan
Nakamoto Medical Clinic
Mito, Ibaraki, 310-0826, Japan
Nakakinen Clinic
Naka, Ibaraki, 311-0113, Japan
Ohishi Naika Clinic
Tsuchiura-shi, Ibaraki, 300-0835, Japan
Morinaga Ueno Clinic
Kumamoto, Kumamoto, 860-0863, Japan
Shiraiwa Medical Clinic
Kashiwara-shi, Osaka, 582-0005, Japan
Suruga Clinic
Shizuoka, Shizuoka, 424-0855, Japan
Yutenji Medical Clinic
Meguro-ku, Tokyo, 153-0053, Japan
Medical Corporation Ouitsukai Kanno Naika
Mitaka-shi, Tokyo, 181-0013, Japan
Salvia-Lekston i Madej Spolka Jawna
Katowice, 40-772, Poland
Centrum Terapii Wspolczesnej J M Jasnorzewska Spolka Komandytowo Akcyjna
Lodz, 90-338, Poland
Clinical Best Solutions Sp zoo Spolka Komandytowa Gabinet Lekarski
Lublin, 20-011, Poland
Ekamed Spolka z Ograniczona Odpowiedzialnoscia
Lublin, 20-718, Poland
Medicome Spolka z Ograniczona Odpowiedzialnoscia
Oświęcim, 32-600, Poland
Velocity Nova Sp zoo Velocity Pulawy
Puławy, 24-100, Poland
NZOZ Przychodnia Specjalistyczna A Wittek H Rudzki spolka jawna
Ruda Śląska, 41-709, Poland
Velocity Nova Sp zoo Velocity Staszow
Staszów, 28-200, Poland
Tomasz Blicharski Lubelskie Centrum Diagnostyczne
Świdnik, 21-040, Poland
Nbr Polska Tomasz Klodawski
Warsaw, 00-710, Poland
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji
Warsaw, 02-507, Poland
Wromedica I Bielicka A Strzalkowska SC
Wroclaw, 51-685, Poland
Latin Clinical Trial Center
San Juan, 00909, Puerto Rico
Korea University Ansan Hospital
Ansan-si, Gyeonggi-do, 15355, South Korea
Yeungnam University Medical Center
Daegu, 42415, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
Korea University Anam Hospital
Seoul, 02841, South Korea
Seoul National University Hospital
Seoul, 03080, South Korea
Kangbuk Samsung Hospital
Seoul, 03181, South Korea
Severance Hospital Yonsei University Health System
Seoul, 03722, South Korea
KyungHee University Gangdong Hospital
Seoul, 05278, South Korea
Asan Medical Center
Seoul, 05505, South Korea
The Catholic University of Korea Seoul St Marys Hospital
Seoul, 06591, South Korea
Hallym University Kangnam Sacred Heart Hospital
Seoul, 07441, South Korea
Yonsei University Wonju Severance Christian Hospital
Wonju-si, Gangwon-do, 26426, South Korea
Ormeau Clinical Trials Ltd
Belfast, BT28BG, United Kingdom
FutureMeds Birmingham
Birmingham, B21 9RY, United Kingdom
Layton Medical Centre
Blackpool, FY3 7EN, United Kingdom
Waterloo Medical Centre
Blackpool, FY4 3AD, United Kingdom
Southmead Hospital
Bristol, BS10 5NB, United Kingdom
Staploe Medical Centre
Ely, CB7 5JD, United Kingdom
FutureMeds Glasgow
Glasgow, G20 7BE, United Kingdom
Hull Royal Infirmary
Hull, HU3 2JZ, United Kingdom
NIHR Leicestershire & Northamptonshire Commercial Research Delivery Centre
Leicester, LE5 4PW, United Kingdom
Aintree University Hospital
Liverpool, L9 7AL, United Kingdom
Clifton Medical Centre
Rotherham, S65 1DA, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
MD
Amgen
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2025
First Posted
March 5, 2025
Study Start
March 17, 2025
Primary Completion (Estimated)
January 21, 2027
Study Completion (Estimated)
April 16, 2027
Last Updated
December 31, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data sharing requests relating to this study will be considered beginning 18 months after the study has ended and either 1) the product and indication have been granted marketing authorization in both the US and Europe or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this study.
- Access Criteria
- Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors. If not approved, a Data Sharing Independent Review Panel will arbitrate and make the final decision. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.
De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.